Literature DB >> 18950554

Neural mechanisms and management of obesity-related hypertension.

Murray D Esler1, Nina Eikelis, Elisabeth Lambert, Nora Straznicky.   

Abstract

The sympathetic nervous system is activated in human obesity and in the analogous experimental obesity produced by overfeeding. The causes remain uncertain and may be multiple. The consequences include hypertension, probably attributable to activation of the sympathetic outflow to the kidneys, and, more disputed, insulin resistance. The pattern of sympathetic activation in normal-weight and obesity-related hypertension differs in terms of the firing characteristics of individual sympathetic fibers (increased rate of nerve firing in normal-weight hypertensives, increased number of active fibers firing at a normal rate in obesity-hypertension) and the sympathetic outflows involved. The underlying mechanisms and the adverse consequences of the two modes of sympathetic activation may differ. Should antihypertensive drug therapy in obesity-hypertension specifically target the existing neural pathophysiology? Such an approach can be advocated on theoretical grounds. Perhaps more important is the requirement that chosen antihypertensives do not cause weight gain or insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18950554     DOI: 10.1007/s11886-008-0072-7

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  48 in total

1.  Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation.

Authors:  Kazuko Masuo; Hideki Kawaguchi; Hiroshi Mikami; Toshio Ogihara; Michael L Tuck
Journal:  Hypertension       Date:  2003-09-02       Impact factor: 10.190

Review 2.  Experimental obesity: a homeostatic failure due to defective nutrient stimulation of the sympathetic nervous system.

Authors:  G A Bray; D A York; J S Fisler
Journal:  Vitam Horm       Date:  1989       Impact factor: 3.421

3.  Antihypertensive effect of alpha- and beta-adrenergic blockade in obese and lean hypertensive subjects.

Authors:  M R Wofford; D C Anderson; C A Brown; D W Jones; M E Miller; J E Hall
Journal:  Am J Hypertens       Date:  2001-07       Impact factor: 2.689

4.  Dissociation between muscle and skin sympathetic nerve activity in essential hypertension, obesity, and congestive heart failure.

Authors:  G Grassi; M Colombo; G Seravalle; D Spaziani; G Mancia
Journal:  Hypertension       Date:  1998-01       Impact factor: 10.190

Review 5.  Central nervous system monoamine neurotransmitter turnover in primary and obesity-related human hypertension.

Authors:  M Esler; G Lambert; M Vaz; J Thompson; D Kaye; V Kalff; M Kelly; A Turner; G Jennings
Journal:  Clin Exp Hypertens       Date:  1997 Jul-Aug       Impact factor: 1.749

6.  Moxonidine improves insulin sensitivity in insulin-resistant hypertensives.

Authors:  A Haenni; H Lithell
Journal:  J Hypertens Suppl       Date:  1999-08

7.  Adverse consequences of high sympathetic nervous activity in the failing human heart.

Authors:  D M Kaye; J Lefkovits; G L Jennings; P Bergin; A Broughton; M D Esler
Journal:  J Am Coll Cardiol       Date:  1995-11-01       Impact factor: 24.094

8.  Pathogenesis of weight-related changes in blood pressure in dogs.

Authors:  A P Rocchini; C P Moorehead; S DeRemer; D Bondie
Journal:  Hypertension       Date:  1989-06       Impact factor: 10.190

Review 9.  The interconnection between sympathetics, microcirculation, and insulin resistance in hypertension.

Authors:  S Julius; T Gudbrandsson; K Jamerson; O Andersson
Journal:  Blood Press       Date:  1992-05       Impact factor: 2.835

10.  Noradrenaline turnover during under- and over-eating in normal weight subjects.

Authors:  K O'Dea; M Esler; P Leonard; J R Stockigt; P Nestel
Journal:  Metabolism       Date:  1982-09       Impact factor: 8.694

View more
  8 in total

Review 1.  Prehypertension: a meta-analysis of the epidemiology, risk factors, and predictors of progression.

Authors:  Xiaofan Guo; Liling Zou; Xingang Zhang; Jue Li; Liqiang Zheng; Zhaoqing Sun; Jian Hu; Nathan D Wong; Yingxian Sun
Journal:  Tex Heart Inst J       Date:  2011

Review 2.  Hypertension in postmenopausal women.

Authors:  Roberta Lima; Marion Wofford; Jane F Reckelhoff
Journal:  Curr Hypertens Rep       Date:  2012-06       Impact factor: 5.369

Review 3.  Mechanisms mediating renal sympathetic nerve activation in obesity-related hypertension.

Authors:  W Chen; S Leo; C Weng; X Yang; Y Wu; X Tang
Journal:  Herz       Date:  2015-04       Impact factor: 1.443

Review 4.  Postmenopausal hypertension.

Authors:  Licy L Yanes; Jane F Reckelhoff
Journal:  Am J Hypertens       Date:  2011-04-21       Impact factor: 2.689

5.  Relationship between body mass index and mean arterial pressure in normotensive and chronic hypertensive pregnant women: a prospective, longitudinal study.

Authors:  Luís Guedes-Martins; Mariana Carvalho; Catarina Silva; Ana Cunha; Joaquim Saraiva; Filipe Macedo; Henrique Almeida; A Rita Gaio
Journal:  BMC Pregnancy Childbirth       Date:  2015-10-30       Impact factor: 3.007

Review 6.  Different effects of prolonged β-adrenergic stimulation on heart and cerebral artery.

Authors:  Eunji Shin; Kyung Soo Ko; Byoung Doo Rhee; Jin Han; Nari Kim
Journal:  Integr Med Res       Date:  2014-10-13

7.  Adverse Reaction of Acupuncture and Antihypertensive Drugs for Treatment of Essential hypertension: A Protocol for Bayesian Network Meta-Analysis.

Authors:  Jiawei Han; Jiwei Yang; Yuanhao Du
Journal:  Comput Intell Neurosci       Date:  2022-08-21

8.  Upregulation of the Renin-Angiotensin-aldosterone-ouabain system in the brain is the core mechanism in the genesis of all types of hypertension.

Authors:  Hakuo Takahashi
Journal:  Int J Hypertens       Date:  2012-12-17       Impact factor: 2.420

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.